Anti-inflammatory response to Cymbopogon citratus (DC.) Stapf extract in non-diabetic chronic kidney disease stage 3: A randomized, double-blind, placebo-controlled clinical trial

Category Primary study
JournalJOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH
Year 2025
This article has no abstract
Epistemonikos ID: cdd524871b8a3d30d76c2279a455a4feac015b8b
First added on: Jan 31, 2025